Valuation (47%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 73.32 | 14.77 |
| PEG Ratio (TTM) | 0.00 | 11.34 |
| P/S Ratio (TTM) | 3.22 | 1.74 |
| P/B Ratio (TTM) | 8.08 | 4.85 |
| P/FCF Ratio (TTM) | -13.18 | 11.26 |
| Price to 5YR AVG Earnings Ratio | 12.19 | 20.73 |
| Price to 5YR AVG FCF Ratio | 64.36 | -24.12 |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.37% | 3.29% |
| ROE (TTM) | 9.31% | 12.55% |
| Net Profit Margin (TTM) | 4.26% | -35.10% |
| ROIC 5YR AVG | 7.33% | 9.20% |
Growth (67%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 66.39% | 196.70% | 4,967.41% |
| Revenue | 2.33% | 4.28% | 14.28% |
| Net Income | 66.42% | 207.54% | 5,035.91% |
| Cash Flow | -58.05% | 8.92% | -12.25% |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.20 | 0.76 |
| Quick Ratio (TTM) | 2.20 | 0.72 |
| D/E Ratio (TTM) | 3.66 | 1.61 |
| Interest Coverage (TTM) | -2.99 | 6.70 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | 1.17 | 1.13 |
| LTL to 5YR AVG FCF | 17.58 | -6.91 |
| Shares Outstanding Growth 5YR AVG | 0.69% | 0.81% |